These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21330095)

  • 1. Evaluation of methadone absorption after topical administration to hospice patients.
    Sylvester RK; Schauer C; Thomas J; Steen P; Weisenberger A
    J Pain Symptom Manage; 2011 May; 41(5):828-35. PubMed ID: 21330095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
    Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
    Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats.
    Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ
    Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the injectable formulation of methadone hydrochloride administered orally in horses.
    Linardi RL; Stokes AM; Barker SA; Short C; Hosgood G; Natalini CC
    J Vet Pharmacol Ther; 2009 Oct; 32(5):492-7. PubMed ID: 19754917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
    Tegeder I; Muth-Selbach U; Lötsch J; Rüsing G; Oelkers R; Brune K; Meller S; Kelm GR; Sörgel F; Geisslinger G
    Clin Pharmacol Ther; 1999 Apr; 65(4):357-68. PubMed ID: 10223771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
    Fredheim OM; Borchgrevink PC; Klepstad P; Kaasa S; Dale O
    Eur J Pain; 2007 Aug; 11(6):599-604. PubMed ID: 17113329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G
    Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats.
    Robertson SA; Taylor PM; Sear JW; Keuhnel G
    J Vet Pharmacol Ther; 2005 Feb; 28(1):87-93. PubMed ID: 15720520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Benzethonium Chloride (CAS No. 121-54-0) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 Jul; 438():1-220. PubMed ID: 12595925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A formal feasibility study of sublingual methadone for breakthrough cancer pain.
    Hagen NA; Moulin DE; Brasher PM; Biondo PD; Eliasziw M; Watanabe SM; Stiles CR
    Palliat Med; 2010 Oct; 24(7):696-706. PubMed ID: 20671005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.